The 100th day of President Donald Trump’s second term marks a significant milestone in his economic agenda, which has been met with widespread criticism and uncertainty. The “sell America” trade policy, aimed at boosting manufacturing through tariffs, has led to trillions of dollars in market value wipeout and an uncertain economic outlook. While the US … Read more
The New York Times offers an All Access subscription that includes news, games, cooking content, audio, and Wirecutter services. Existing subscribers are not eligible for this offer. The monthly rate is €2.00 every 4 weeks for the first 6 months, then €12.00 every 4 weeks. For an annual plan, the initial fee is €20.00 for … Read more
Samsung is set to launch its latest foldable phones, the Galaxy Z Fold7 and Z Flip7, in early July. The company will hold an in-person event in New York at the start of the month, as confirmed by a report from South Korean publication The JoongAng. The leak aligns with previous reports and suggests that … Read more
Episode three of The Last of Us season two is a masterclass in storytelling, expertly resetting the audience’s emotions and expectations. After Joel’s brutal murder at the hands of Abby, the people of Jackson decide to take revenge on her group. However, this plan hits a snag when the town council rejects it, citing concerns … Read more
A new report from Apollo chief economist Torsten Slok suggests that a sweeping “Liberation Day” tariff announced in April could lead to a recession in the US by summer. Slok now estimates the probability of this scenario at 90%. The tariffs, which President Trump has placed on Chinese imports, will likely disrupt global trade and … Read more
Apple has released the latest beta updates across its software platforms, including watchOS 11.5, visionOS 2.5, tvOS 18.5, and more. The new update, beta 4, is expected to focus on bug fixes and performance improvements rather than new features. This release comes a week after the previous developer betas, indicating that Apple has no major … Read more
Pfizer has announced the results from a phase 3 bladder cancer trial, showing that its PD-1 inhibitor sasanlimab reduced the risk of disease-related events by 32%. However, the study did not demonstrate overall survival benefits and saw an increased rate of serious adverse events in the treatment arm. The trial found patients who received sasanlimab … Read more
Japan’s benchmark stock index rebounded, wiping out all losses caused by US President Donald Trump’s trade announcement, as improved trade talks and a weaker yen boosted investor confidence. Toyota Motor Corp. also surged 3.6% after its chairman proposed a buyout of another company in the group. Source: https://www.bloomberg.com/news/articles/2025-04-28/japan-stocks-rise-on-tariff-calm-toyota-surges-on-buyout-report
Get ready to score some amazing deals at Walmart! Our team is curating the best bargains for you, including top-rated AirPods Pro 2 earbuds, a portable Fujifilm photo printer, and an Aroma six-cup rice cooker. Don’t miss out on these incredible savings – they may disappear soon. CNET’s audio expert David Carnoy praises the AirPods … Read more
A new treatment for bladder cancer has shown promising results in a phase 2 trial. TAR-200, an intravesical drug-releasing system, provided durable disease-free survival outcomes in patients with high-risk, BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC) who had papillary-only disease. According to the study’s lead author, Felix Guerrero-Ramos, MD, PhD, patients treated with TAR-200 experienced a 95.6% … Read more